Laxxon Medical Ltd. develops and commercializes additive-manufactured pharmaceutical dosage forms and drug-delivery systems based on its SPID®-Technology. The company provides pharmaceutical partners with services including patent extension via technology transfer, advanced patented generics, and new drug development, supporting activities from R&D through scalable production.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Drug Development and Manufacturing with SPID® Technology
Drug development, engineering and manufacturing with SPID® Technology for oral, transdermal and implantable dosage forms; small batches for research and clinical studies through to industrial production.
Patent Extension through Technology Transfer
Optimization and reformulation of marketed pharmaceutical products nearing patent expiry, including new registration and additional patent protection based on Laxxon IP.
Patented Generics
Repurposing, repositioning and relaunching generic active ingredients with patent protection; registration via 505(b)(2) in the US and hybrid applications in the EU.
New Drug Development
Research, development, engineering and manufacturing for new drugs, including small batches for preclinical and clinical studies and scale-up to industrial production.
Development and Manufacturing Partnerships with Pharma Companies
Partnerships with pharmaceutical companies for research, development, engineering and manufacturing; collaboration with external partners for in-house and joint projects.
Comparisons
Laxxon Medical Ltd. in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Laxxon Medical Ltd. by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Laxxon Medical Ltd. has claimed this profile, we'll publish editorial articles and case studies here together.